AzTrials
AzTrials

Diabetic FootNCT06518486

Foot-Ankle Exercise and Walking Exercise on Diabetes Mellitus Patients

A study testing Foot-ankle exercise and Walking exercise in people with Diabetic Foot and Diabetes Mellitus, Type 2, run by Taipei Medical University at 5 sites in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary purpose of this study is to determine the effectiveness of foot-ankle exercise and walking exercise on foot neuropathy, stress, and quality of life (QoL) among people with diabetes mellitus (PWDM). Read more about this study

Who is it for?
Ages 20 to 70 yearsHealthy volunteers can take part
What is being tested?
Foot-ankle exercise and Walking exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
375 participants
Where
5 sitesIndonesia
Study dates
4 Oct 2024to 15 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • People with type 2 diabetes
  • Aged 20-70 years
  • Diagnosed with DM for at least 1 year
  • Can walk without assistance
  • Able to communicate well
  • Can read and write
  • Willing to be a respondent

Who cannot join

  • Has a history of leg amputation
  • Have a diagnosis of heart failure, kidney failure, pulmonary TB, stroke
  • Patients with a history or under-treatment of mental disorders
  • DM patients with foot ulcers
  • DM patients with fractures or difficulty using the lower extremities

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

Indonesia5 sites
  • Puskesmas Batang

    Batang, Central Java

  • Puskesmas Musuk

    Boyolali, Central Java

  • DPM Alexander

    Sleman, Special Region of Yogyakarta

  • Puskesmas Kalasan

    Sleman, Yogyakarta and West Nusa Tenggara

  • UPT Puskesmas Lunyuk

    Sumbawa, West Nusa Tenggara

Other trials in Indonesia

About this study

Official title: The Effectiveness of Foot-Ankle Exercise and Walking Exercise on Foot Neuropathy, Stress, Quality of Life, Blood Sugar Markers, Blood Pressure, Ankle-Brachial Index, and BMI Among Diabetes Mellitus Patients

The primary purpose of this study is to determine the effectiveness of foot-ankle exercise and walking exercise on foot neuropathy, stress, and quality of life (QoL) among people with diabetes mellitus (PWDM). At the same time, the secondary purpose of this study is to determine the effectiveness of foot-ankle exercise and walking exercise on body mass index (BMI), fasting blood glucose (FBG), blood pressure (BP), and ankle-brachial index (ABI) among PWDM at baseline (before intervention/0 week), at 6-weeks and 12-weeks.

The research questions in this study include the following:

Read more
  • Is foot-ankle exercise effective for foot neuropathy, stress, QoL, BMI, FBG, BP, and ABI for PWDM?
  • Is walking exercise effective for foot neuropathy, stress, QoL, BMI, FBG, BP, and ABI for PWDM?
  • Are there any differences in the mean scores of foot neuropathy, stress, QoL, BMI, FBG, BP, and ABI of PWDM within and between the foot-ankle exercise, walking exercise and control group at baseline, 6 weeks, and 12 weeks?
  • Are there any mediators/moderators effect of BMI, FBG, blood pressure, ABI, and stress for influencing foot exercise and walking exercise interventions on foot neuropathy and QoL for PWDM?

Participants in the foot-ankle exercise group will be given health education about DM and foot-ankle exercise, as well as leaflets and videos. Participants will be taught how to practice foot-ankle exercises before the instructor. Afterwards, participants will practice foot-ankle exercises independently without supervision for 2-3 sessions every day for 12 weeks. Participants in the walking exercise group will be given health education about DM, walking exercises and leaflets. Participants will practice walking exercises independently without supervision for 12 weeks. Participants are advised to do walking exercises with a minimum duration of 10 minutes for each session and 150 minutes/week. Two consecutive days without walking exercise are not allowed. Participants in the control groups will be treated as active control and given health education on general DM topics and leaflets. All groups received usual care according to standards provided by public health services. Researchers will compare the groups to see the effect of the interventions on foot neuropathy, stress, QoL, BMI, FBG, BP, and ABI at three different time points: at baseline, 6 weeks, and 12 weeks.

Read the detailed description

Intervention Development

This study focused on foot-ankle exercises modified from previous research and adapted to exercises developed by the Indonesian Endocrinology Association. Providing health education about DM in general and foot-ankle exercise is intended to increase participants' basic knowledge about DM and the importance of foot-ankle exercises. Foot-ankle exercise simulation and practice aim to ensure participants can do it well and independently. The leaflet contains the material presented during health education and is given to participants. A video was made containing the steps to do foot-ankle exercises. Researchers will upload videos of the foot-ankle exercises to YouTube. Participants will be given the video in soft file form and informed that they can access it via the researcher's YouTube channel. Walking exercises in this study adapted and modified from previous research. Providing health education about DM in general and walking exercises is intended to increase participants' basic knowledge about DM and the importance of walking exercise exercises. The leaflet contains the material presented during health education and is given to participants in walking exercise groups.

Content Validity

The content validity test in this study aims to validate the intervention procedures used during the research process. The details are: detail intervention of foot-ankle exercise and walking exercise, health education materials and leaflets for the control group, foot-ankle exercise groups, and walking exercise groups, videos of foot ankle exercises, standard operational procedures for measuring foot sensation and foot vibration, height and weight, BP, and ABI. The criteria for Experts: 1) Willing to be involved in the content validity study, 2) Doctor/nurse, 3) Have experience working in the clinical or research area on the topic of diabetes mellitus for more than 5 years. In this study, six experts are needed to achieve a content validation index (CVI) satisfaction of 0.83. Researchers will send formal invitations via email to experts. The files include an application letter, a cover letter containing the research objectives, expert panel criteria, intervention procedures to be assessed, and an assessment sheet. Assessment of each item uses a 1-4 Likert scale. Item with score <3 will be asked to provide comments or suggestions to help further refine the intervention protocol. Researchers will use item-level CVI (I-CVI) and the scale-level (S-CVI). The CVI value is satisfactory if I-CVI ≥0.80 and S-CVI ≥0.83. Items with a low CVI value will be revised according to the comments and suggestions of experts until the CVI value becomes satisfactory.

Participants Recruitment Process

Researchers will ask the District Health Service for information about public health centers (PHCs) with active Chronic Disease Management Program (PROLANIS) activities. Researchers will contact and collaborate with PHCs for participant recruitment. The research team will contact each potential participant and explain the research process. Researchers will also put-up posters in PHCs and also distribute these posters through social media. Potential participants willing to become participants can contact the contacts listed on the poster. For potential respondents who are willing, after signing the informed consent, they will be included in the chat group. Participants will be given a transportation fee of IDR 25,000 for each arrival during the data collection process.

Sample Size Calculation

Samples were calculated using G*Power sample size calculator v.3.1. using F test with an analysis of variance based on some criteria. Researchers will use small effect size (0.1), an α error probability of 0.05, and a power of 0.95; Number of groups 3 (foot-ankle exercise, walking exercise, and control group); and number of measurements 3 (baseline, 6-weeks, and 12 weeks). Based on the calculation, 312 participants were needed; and added an anticipated dropout of 20% (63 people), so the total sample size was 375. The total sample was divided into three groups; each group had 125 participants.

Randomization and Allocation Concealment

Eligible participants will be randomized by independent staff not involved in the recruitment and data collection process, with a ratio of 1:1:1 for each group. After baseline measurements, the randomization process will be carried out using the computer-generated randomization method. The method that will be used is random permuted blocks with size 3, 6, 9. The random numbers will be packaged in sequence, stored and locked in opaque envelopes to guarantee allocation concealment. This sequence will be kept private and stored in a place that assessors cannot access.

Intervention Delivery

Control group: The active control group was given health education on the topic of DM for 30 minutes and then given a leaflet.

Foot-ankle exercise group: Participants will be given health education on DM and foot-ankle exercise after the allocation procedure, followed by simulation and practice lasts 60 minutes. Participants were also given leaflets and videos to take home. Afterward, participants will practice independently without supervision for 12 weeks. Foot-ankle exercise consists of 10 movements. When doing foot exercises, participants sit comfortably without leaning, and the soles of their feet touch the floor and barefoot. These movements are:

A 1)Lift the soles of the feet with heels still touching the floor.2)Toes are bent to grip like chicken claws in this position.3)Repeat this movement 10x.

B 1)Lift the soles of the feet with heels still touching the floor. 2)Lower the soles of feet and raise heels with toes touching the floor. 3)Repeat this movement 10x.

C 1)Lift the soles of the feet with heels still touching the floor.2)Do circular movements from the inside to the outside for the soles of both feet.3)Repeat this movement 10x.

D 1)Lift the heels of both feet with toes still touching the floor.2)Do circular movements from the inside to the outside for the soles of both feet.3)Repeat this movement 10x.

E 1)Lift right knee and straighten it. The left leg remains in its original position.2)Move toes forward and backward.3)Repeat this movement 10x.4)Do the same for the left leg.

F 1)Lift right knee and straighten it.2)The left leg remains in its original position.3)Move toes towards face.4)Repeat this movement 10x.5)Do the same for the left leg.

G 1)Lift both knees of the right and left legs, then straighten them.2)Move toes towards face at the same time.3)Repeat this movement 10x.

H 1)Lift both knees of the right and left legs, then straighten them.2)Move both legs forward.3)Repeat this movement 10x.

I 1)Lift their right knee and straighten it. The left leg remains in its original position.2)Write the numbers 1-10 with feet.3)Do the same movement for the left leg.

J 1)Place newspapers as a base for the soles.2)Shape the newspaper into a ball using both feet.3)Open the newspaper ball again to become sheet-like before using both feet.4)Divide the newspaper into two parts using both feet.5)Tear one part of the newspaper into small pieces and collect it on top of the other part of the newspaper.6)The newspaper sheet containing small shreds is made into a ball using both feet.7)Throw the newspaper ball into the trash.

Walking exercise group: Participants will be given health education for 30 minutes, on DM and walking exercises and leaflet after the allocation procedure. Participants will practice walking exercises independently for 12 weeks.

Health education for all groups is provided by persons who have certificates as DM educators and carried out in subgroups with 7-10 members in each group. To avoid contamination, health education was implemented at different times, Fridays for control group, Saturday for foot-ankle exercise group, and Sunday for walking exercise group, with flexible implementation hours according to the agreement of each group. All group participants were included in the chat group (Whatsapp Messenger) so that researchers could communicate and monitor the implementation of the intervention.

Interventionist dan Outcome Investigators

Each research location has 1 health professional who carries out the intervention with criteria: having a master's degree in nursing, working as a health worker/health educator for at least 5 years, and having a certificate as a DM educator. Each research location has at least of 1 outcome investigator with the criteria of a health worker with a registration certificate.

Plan for Data Management/Analysis

Data analysis will use the intention to treat (ITT) principle. In addition, an analysis using the per-protocol (PP) principle will be carried out. Then, Researchers will compare the analysis results using ITT and PP and conduct a sensitivity test. The data analysis process uses the SPSS V.27 program. Researchers will conduct a normality test using the Kolmogorov Smirnov test; the data distribution is normal if the value is> 0.05. Researchers will use the Generalized Estimating Equation (GEE) test to analyze changes in outcomes between the foot-ankle exercise group vs control group, walking exercise group vs control group, and foot-ankle exercise group vs walking exercise group over time (baseline, six weeks, and 12 weeks). Baseline measurement and control group as reference. The significance value uses p value <0.05.

Comparison data of baseline respondents between the 3 groups for categorical data will be analyzed by the Chi-square/Fisher Exact test; for numerical data, ANOVA test for normal distributed or Friedman test for non-normally distributed. If a significant imbalance is found, an appropriate covariance adjustment analysis will be carried out in the data analysis. Analysis within group for each measurement time (baseline vs six weeks, baseline vs 12 weeks, six weeks vs 12 weeks) will use the Paired T-test if normally distributed or the Wilcoxon test if non-normally distributed. Meanwhile, the analysis between groups for each measurement time (T0, T1, and T2) will use the Independent T-test for normally distributed or the Mann-Whitney test for non-normally distributed.

Researchers will use path analysis to analyze the mediation/moderator of BMI, FBG, BP, ABI, and stress on the effects of foot-ankle exercise and walking exercise on foot sensitivity and QoL. The mediation analysis will use the bootstrap technique as a nonparametric procedure to test the statistical significance of various Partial Least Squares-Structural Equation Model (PLS-SEM) results, such as path coefficients. Researchers will use the software program SmartPLS 3 (SmartPLS GmbH, Bo¨nningstedt, Germany) to analyze the mediation effects. For PLS-SEM, Standard Root Mean Square Residual/SRMR can be used as a goodness-of-fit test to prevent model specification errors. SRMR is the difference between the observed correlation and the model's implied correlation matrix. As a result, it is possible to use the average magnitude of the difference between measured and predicted correlations as an absolute measure of (model) goodness-of-fit. A good fit is described as a value smaller than 0.10 or 0.08. The statistically significant level was set at 0.05 and 95% confidence intervals (CI) to test indirect effects. The result indicates a significant level if the 95% CI does not contain zero.

Monitor for Adverse Events

Adverse events that have the potential to occur include fatigue, muscle aches, pain and dizziness. Participants will record for themselves if adverse events occur and report to the team. The research team also monitored by telephone once a week, asking whether any adverse events had occurred and recording them. If excessive adverse events occur, investigators will immediately stop the intervention and carry out treatment.

Being tested
Foot-ankle exercise, Walking exercise, Usual care and health education
Keywords
Foot sensitivity, Stress, Quality of life, Fasting blood glucose, Body mass index, Blood pressure, Ankle-brachial index, Diabetes mellitus, Diabetic peripheral Neuropathies
Medical subject headings
Diabetic Foot, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Diabetes Mellitus, Diabetes Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Foot-ankle exerciseOther

    Foot-ankle exercise group will receive usual care provide by public health center and intervention through health education, leaflets, and videos about foot-ankle exercise. At the first meeting, participants will be taught how to do foot exercises and practice them in front of the instructor. Afterwards, participants will practice foot exercises independently without supervision for 12 weeks. One foot exercise session takes 10-15 minutes, while the physical activity target is for participants to fulfil a moderate level of physical activity (150 minutes/week). For this reason, participants are advised to do foot exercises for 2-3 sessions every day. The minimum duration of each session is 10 minutes, and two consecutive days without foot exercise are not allowed. Participants are asked to document all foot exercise practices in the logbook given at the first meeting. To monitor the intervention, we will contact participants by telephone for ±5 minutes/week.

  • Walking exerciseOther

    Participants in the walking exercise group will receive usual care provide by public health center and intervention through health education and leaflets about walking exercise. Participants will practice walking exercises independently without supervision for 12 weeks. Participants walked at the same speed as they did every day. The physical activity target to be achieved is for participants to be able to engage in a moderate level of physical activity (150 minutes/week). For this reason, participants are advised to do walking exercises with a minimum duration of 10 minutes for each session. Two consecutive days without walking exercise are not allowed, and a minimum of 150 minutes/week is allowed. Participants are asked to document all walking exercise practices in the logbook given at the first meeting. To monitor the intervention, we will contact participants by telephone for ±5 minutes/week.

  • Usual care and health educationOther

    Participants in the control group will receive the usual care provided by the community health center and intervention in the form of health education about DM in general.

Study groups in NCT06518486
Study groupRoleWhat they receive
Foot-ankle exercise groupExperimentalThe group received intervention through health education, simulations, leaflets, and videos about foot-ankle exercise and practised independently for 12 weeks.
Receives: Other: Foot-ankle exercise
Walking exercise groupExperimentalThe group received intervention through health education, and leaflets about walking exercise and practised independently for 12 weeks.
Receives: Other: Walking exercise
Control groupActive comparatorThe group that received intervention in the form of health education and leaflets about DM in general.
Receives: Other: Usual care and health education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Foot Neuropathy of People with Diabetes Mellitus

    Foot neuropathy will be measured by MNSI. MNSI consist of MNSI-A (questionnaire) and MNSI-B (physical examination). Foot sensation will be measured using Semmes Weinstein Monofilament 10g. Participants will be given a stimulus for 1.5-2 seconds at 10 points on both legs. The locations are heel, dorsal surface of the foot (between the bases of 1st-2nd toes), toes (1st, 3rd, and 5th), metatarsal heads (1st, 3rd, 5th), and midfoot (medial and lateral). The results range from 0-10. Foot vibration measurement using Tunning Fork 128Hz. The vibrating TF will be placed on each leg in 4 locations (medial, malleolus, great toe, fifth toe). Participants were asked to feel the vibrations and signal by raising their hands if they were no longer felt. The observer will record the time from when the participant feels the initial until it disappears. The results consist of whether the participant felt the vibration or not (0-4) and the length of time participants can feel the vibration (in seconds).

    Measured: Baseline (before intervention/0 week), at 6-weeks and 12-weeks

  2. Stress of People with Diabetes Mellitus

    Stress will be measured using the Indonesian version of the Problem Areas in Diabetes (PAID) questionnaire. This study uses PAID Bahasa Indonesia, which we have previously tested for validity and reliability. PAID Bahasa Indonesia has 20 items and three factors, with a loading factor of 0.349-0.779 for each item. The results of exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) show valid and reliable results. Cronbach's alpha for all items is 0.858, inter-class correlation 0.938, RMSEA=0.058, and SRMR=0.062. PAID Bahasa Indonesia consist of five answer choices using a Likert scale (0-4). The answer choice scores used were 'not a problem' (0), 'minor problem' (1), 'moderate problem' (2), 'somewhat serious problem' (3), and 'serious problem' (4). The total score ranged 0-80, with a higher score indicating greater stress.

    Measured: Baseline (before intervention/0 week), at 6-weeks and 12-weeks

  3. Quality of Life of People with Diabetes Mellitus

    QoL will be measured using the Indonesian version of the Diabetes Obstacles Questionnaire Short Version (DOQ-30) which we have previously tested for validity and reliability. DOQ-30 Bahasa Indonesia has nine factors and a 5-point Likert scale with answer options never (5), almost never (4), sometimes (3), often (2), and always (1). The total score ranges 30-150, with a higher score indicating a better QoL. Factors in the DOQ-30 are relationships with medical professionals, support from friends and family, knowledge of the disease, lifestyle changes, exercising, self-monitoring, uncertainty about a consultation, medication, and insulin use. EFA and CFA analysis showed valid and reliable results; Cronbach's alpha for all items was 0.930, and individual factors ranged from 0.730 to 0.848. The test-retest results were excellent (with interclass correlation coefficients of 0.910 to 0.973). The CFA test obtained RMSEA=0.057 and SRMR=0.067, indicating a good model fit.

    Measured: Baseline (before intervention/0 week), at 6-weeks and 12-weeks

Secondary outcomes (5)
  1. Fasting Blood Glucose (FBG) of People with Diabetes Mellitus

    FBG were measured using venous blood after the respondent fasted for at least 8 hours. Blood analysis is carried out in the laboratory using the hexokinase enzymatic method. The researchers did not carry out this analysis, but they collaborated with the Independent Clinical Laboratory. All participants were measured according to standard operating procedures as a guide. The measurement results are documented in the observation sheet. The process of taking venous blood is carried out by nursing staff with the criteria of having a competency certificate and working for a minimum of 3 years.

    Measured: Baseline (before intervention/0 week), at 6-weeks and 12-weeks

  2. Blood Pressure of People with Diabetes Mellitus

    Blood pressure will be measured using a digital tensimeter, The Omron M3 Intellisense (Omron Healthcare Co Ltd), validated in previous research. Participants were asked to rest for at least 5 minutes before the measurement. Measurements were taken on the left arm in a sitting or supine position. Blood pressure consists of SBP and DBP in mmHg units. Then, the mean atrial pressure (MAP) will be calculated using the formula, MAP = DBP + 1/3(SBP - DBP) or MAP = DBP + 1/3(pulse pressure/PP) All participants were measured according to standard operating procedures as a guide. The measurement results are documented in the observation sheet.

    Measured: Baseline (before intervention/0 week), at 6-weeks and 12-weeks

  3. Body Mass Index of People with Diabetes Mellitus

    Participants were asked to stand up straight and remove footwear when their height and weight were checked. Body weight was measured using digital scales, and height using height-measuring devices. BMI is calculated using the formula body weight (kg) divided by height2 (m2). All participants were measured according to standard operating procedures as a guide. The measurement results are documented in the observation sheet.

    Measured: Baseline (before intervention/0 week), at 6-weeks and 12-weeks

  4. Ankle-Brachial Index (ABI) of People with Diabetes Mellitus

    ABI measurements will be carried out using continuous-wave Doppler ultrasound using SOPs prepared previously. Participants were asked to rest for at least 5 minutes, and measurements were taken in the supine position. BP was measured twice each at four locations: right arm, left arm, right leg and left leg. Arm blood pressure was measured by Doppler ultrasound in the humeral artery, while leg blood pressure was placed in the tibial artery. The cuff is inflated 20-30 mmHg and deflated slowly. The first sound heard is systolic blood pressure. The average blood pressure results from the two measurements at each location will be calculated to obtain the average blood pressure in the right arm, left arm, right leg and left leg. ABI will be calculated using the ankle SBP/brachial SBP formula. The results of these calculations produce the right and left ABI. The analysis will use the lowest ABI value between the two legs. The measurement results are documented in the observation sheet.

    Measured: Baseline (before intervention/0 week), at 6-weeks and 12-weeks

  5. Adherence Participants in Experimental Group

    The compliance of participants in both intervention groups in carrying out the program provided was measured using documentation from the logbook at the beginning of the meeting. The logbook contains information on the day, date, and time from start to finish, and it ends with the participant's signature.

    Measured: 12-weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2024
  2. Study start4 Oct 2024
  3. Primary completion15 Jan 2025
  4. Study completion15 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Three arms parallel group design with 2 group interventions (foot-ankle exercise and walking exercise) and 1 control group
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
375 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06518486
Sponsor's protocol ID
RCT2024_Siti Fadlilah
Status last verified
Feb 2025
First submitted
18 Jul 2024
Last updated
3 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Particular data will be shared: Individual participant data that underlie the results reported in this article after identification (text, tables, figures, and appendices).

Publications

  • Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW, Feldman EL; DCCT/EDIC Research Group. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med. 2012 Jul;29(7):937-44. doi: 10.1111/j.1464-5491.2012.03644.x.

    PubMed 22417277
  • Yang MC, Huang YY, Hsieh SH, Sun JH, Wang CC, Lin CH. Ankle-Brachial Index Is Independently Associated With Cardiovascular Outcomes and Foot Ulcers in Asian Patients With Type 2 Diabetes Mellitus. Front Endocrinol (Lausanne). 2021 Nov 18;12:752995. doi: 10.3389/fendo.2021.752995. eCollection 2021.

    PubMed 34867797
  • Welch GW, Jacobson AM, Polonsky WH. The Problem Areas in Diabetes Scale. An evaluation of its clinical utility. Diabetes Care. 1997 May;20(5):760-6. doi: 10.2337/diacare.20.5.760.

    PubMed 9135939
  • Weinstein AR, Sesso HD, Lee IM, Cook NR, Manson JE, Buring JE, Gaziano JM. Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA. 2004 Sep 8;292(10):1188-94. doi: 10.1001/jama.292.10.1188.

    PubMed 15353531
  • Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010 Oct;33(10):2285-93. doi: 10.2337/dc10-1303.

    PubMed 20876709
  • Suryani M, Samekto W, Heri-Nugroho, Susanto H, Dwiantoro L. Effect of foot-ankle flexibility and resistance exercise in the secondary prevention of plantar foot diabetic ulcer. J Diabetes Complications. 2021 Sep;35(9):107968. doi: 10.1016/j.jdiacomp.2021.107968. Epub 2021 May 28.

    PubMed 34187716
  • Soleimani Tapehsari B, Alizadeh M, Khamseh ME, Seifouri S, Nojomi M. Physical Activity and Quality of Life in People with Type 2 Diabetes Mellitus: A Randomized Controlled Trial. Int J Prev Med. 2020 Jan 24;11:9. doi: 10.4103/ijpvm.IJPVM_202_18. eCollection 2020.

    PubMed 32089809
  • Diabetes Canada Clinical Practice Guidelines Expert Committee; Sigal RJ, Armstrong MJ, Bacon SL, Boule NG, Dasgupta K, Kenny GP, Riddell MC. Physical Activity and Diabetes. Can J Diabetes. 2018 Apr;42 Suppl 1:S54-S63. doi: 10.1016/j.jcjd.2017.10.008. No abstract available.

    PubMed 29650112
  • Shah SZA, Karam JA, Zeb A, Ullah R, Shah A, Haq IU, Ali I, Darain H, Chen H. Movement is Improvement: The Therapeutic Effects of Exercise and General Physical Activity on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diabetes Ther. 2021 Mar;12(3):707-732. doi: 10.1007/s13300-021-01005-1. Epub 2021 Feb 5.

    PubMed 33547579
  • Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA; IWGDF Editorial Board. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3266. doi: 10.1002/dmrr.3266.

    PubMed 32176447
  • Park S, Kim J, Lee J. Effects of Exercise Intervention on Adults With Both Hypertension and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis. J Cardiovasc Nurs. 2021 Jan/Feb;36(1):23-33. doi: 10.1097/JCN.0000000000000651.

    PubMed 32011348
  • Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010 Mar 23;340:c869. doi: 10.1136/bmj.c869. No abstract available.

    PubMed 20332511
  • Rac-Albu M, Iliuta L, Guberna SM, Sinescu C. The role of ankle-brachial index for predicting peripheral arterial disease. Maedica (Bucur). 2014 Sep;9(3):295-302.

    PubMed 25705296
  • Lu B, Hu J, Wen J, Zhang Z, Zhou L, Li Y, Hu R. Determination of peripheral neuropathy prevalence and associated factors in Chinese subjects with diabetes and pre-diabetes - ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SH-DREAMS). PLoS One. 2013 Apr 16;8(4):e61053. doi: 10.1371/journal.pone.0061053. Print 2013.

    PubMed 23613782
  • Kirwan JP, Sacks J, Nieuwoudt S. The essential role of exercise in the management of type 2 diabetes. Cleve Clin J Med. 2017 Jul;84(7 Suppl 1):S15-S21. doi: 10.3949/ccjm.84.s1.03.

    PubMed 28708479

Questions about this trial

What is this clinical trial studying?

A study testing Foot-ankle exercise and Walking exercise in people with Diabetic Foot and Diabetes Mellitus, Type 2, run by Taipei Medical University at 5 sites in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Foot Neuropathy of People with Diabetes Mellitus (time frame: Baseline (before intervention/0 week), at 6-weeks and 12-weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06518486, which also lists 90 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in